Figure 6.
Frequency of nonsynonymous single nucleotide variants in 6 canonical protein-coding genes in EBV genomes from 6 global regions. All 6 genes have been the focus of EBV vaccine development efforts. The frequency (%) is calculated as the (number of EBV genomes from each region carrying the indicated sequence variant)/(total number of EBV genomes analyzed from that region) × 100.